Results
Emcure FY26 Revenue Growth 16.6%, Margin Expansion
Emcure Pharmaceuticals reported FY26 revenue of ₹9,204 Cr, a 16.6% YoY growth, exceeding guidance with strong international performance.
EBITDA margin expanded 80 bps to 19.4% and Adj. PAT margin impr
